Search for: "Glenmark Generics Inc." Results 1 - 20 of 50
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
10 Jun 2021, 8:11 am by Dan Bressler
Barclay Surrick, Glenmark Pharmaceuticals Inc. said there was a glitch that corrupted a portion of the recording of the May 5 hearing in Pennsylvania federal court, including during the testimony of the company’s general counsel who waived any purported conflict of interest created by Morgan Lewis’ work on behalf of co-defendant Teva Pharmaceuticals in separate civil litigation. [read post]
30 Apr 2021, 8:07 am by Dan Bressler
Barclay Surrick to require Morgan Lewis to answer a series of questions about its ability to ethically represent Glenmark Pharmaceuticals Inc. [read post]
17 May 2016, 8:30 pm by Patent Docs
Glenmark Pharmaceuticals Inc., USA the Federal Circuit demonstrated the resulting equipoise in affirming a district court's determination that the doctrine applied to an accused infringing generic formulation. [read post]
13 May 2015, 8:44 pm by Patent Docs
Glenmark Generics Inc USA 3:15-cv-01416; filed May 6, 2015 in the Northern District of Texas • Plaintiffs: Galderma Laboratories LP; Galderma SA; Galderma Research & Development SNC • Defendant: Glenmark Generics Inc USA; Glenmark Generics Ltd. [read post]
21 Oct 2014, 12:00 am
 In Glenmark Generics (Europe) Limited & others v The Wellcome Foundation Limited & Glaxo Group Ltd, [2013] EWHC 148 (Pat), reported by the IPKat here, Arnold J decided that a combination product for treating malaria was obvious. [read post]
14 Sep 2014, 9:59 pm by Patent Docs
• Defendants: Glenmark Pharmaceuticals Ltd.; Glenmark Generics Ltd.; Glenmark Generics Inc. [read post]
27 Jul 2014, 9:38 pm by Patent Docs
Glenmark Generics Inc. [read post]
17 Jul 2014, 10:58 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.;… [read post]
30 Jun 2014, 10:28 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited; Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global FZE; Caraco Pharmaceutical Laboratories, Ltd.;… [read post]
15 Jun 2014, 8:46 pm by Patent Docs
Ferring, B.V. 3:14-cv-00422; filed June 9, 2014 in the Eastern District of Virginia • Plaintiffs: Glenmark Generics Ltd.; Glenmark Generics Inc., USA • Defendant: Ferring, B.V. [read post]
17 Mar 2014, 11:03 am
Reddy's Laboratories, Inc.; Glenmark Generics Inc., USA; Glenmark Generics Ltd.; Glenmark Pharmaceuticals Ltd.; Hetero USA Inc.; Hetero Labs Limited; Hetero Labs Limited Unit V; Hetero Drugs Ltd.; Mylan Pharmaceuticals Inc.; Mylan Inc.; Mylan Laboratories Limited (these three companies are, collectively, "Mylan"); Par Pharmaceutical Companies, Inc.; Par Pharmaceutical, Inc.; Sun Pharma Global… [read post]
2 Feb 2014, 9:33 pm by Patent Docs
Glenmark Generics Inc., USA 1:14-cv-00104; filed January 23, 2013 in the Southern District of Indiana Infringement of U.S. [read post]
30 Jan 2014, 10:36 am
Indianapolis, Indiana - Indiana patent attorneys for Eli Lilly and Company of Indianapolis, Indiana ("Lilly") filed a lawsuit in the Southern District of Indiana alleging that Glenmark Generics, Inc., USA of Mahwah, New Jersey ("Glenmark") infringed Antifolate Combination Therapies, Patent No. 7,772,209, which has been issued by the U.S. [read post]
28 Apr 2013, 10:39 pm by Shouvik Kumar Guha
The text is due to be transmitted to the WIPO General Assembly in September, 2013. [read post]
15 Apr 2013, 6:39 am by Lebowitz & Mzhen
Last February alone, Glenmark Generics and Pfizer, Inc. issued individual recalls for birth control pills which were packaged in the incorrect order. [read post]
2 Apr 2013, 10:33 am by Anubha Sinha
 The generic v. innovator battle has moved on to anti-diabetic drugs, with Glenmark has launched a cheaper generic version of pharma multinational Merck’s blockbuster anti-diabetes drug Januvia (Sitagliptin phosphate), as reported by Madhulika Vishwanathan here. [read post]